RiceBran Technologies (NASDAQ:RIBT) (the "Company"), a global leader in the development and manufacture of nutritional and functional ingredients derived from rice and other small and ancient grains for human food, nutraceutical, pet care and equine feed applications, today announced financial results for the third quarter ended September 30, 2022.

* Reconciliation of GAAP to Non-GAAP measures follows.

Third Quarter 2022 Operating Highlights

"RiceBran continues to take advantage of strong demand for its products. We delivered another $10 million quarter, with year-over-year revenue up 48%," said Executive Chairman Peter Bradley. "Our specialty milling businesses are running well and capitalizing on a strong demand for high-quality domestically supplied grains, and we saw double-digit growth in Core-SRB sales for the third quarter in a row. We are making progress with our initiatives to transition the Company to profitability. Our new Golden Ridge partnership and MGI's capacity expansion will drive improved contributions from the mills in the near term, and we are pushing hard to get to our Core-SRB targets and to reaccelerate Value-Add sales and introduce new products."

• Improved sourcing and selling to enhance Golden Ridge contribution. Golden Ridge continues to generate strong sales growth due to operating improvements. In September, the Company signed an operating agreement that will provide the mill with enhanced sourcing and selling capabilities, which is expected to result in improved profitability beginning in the fourth quarter. Deferred maintenance ahead of this transition contributed to higher gross losses in the third quarter, but a positive contribution margin is expected when these activities are fully transferred by year end.
• MGI generates strong growth while undergoing capacity expansion. In the third quarter, MGI completed all but one segment of a major mechanical upgrade, which will add 50% throughput capacity to the mill. Despite the significant operating challenges while executing during this project, the mill continued to generate strong year-over-year growth in both revenue and contribution margin. The capacity expansion tied to this investment is already booked through 2023, with some benefit expected in the fourth quarter despite delays in obtaining key equipment for the project due to supply chain issues.
• New customer wins for core-SRB business to ramp slower than expected. Core-SRB sales were up double-digits year-over-year for the third quarter in a row. The Company began supplying a new pet food customer in August, but volumes for this business will fall short of expectations in the fourth quarter due to a technical issue. This issue was known when shipments began but will need to be remediated sooner than expected to achieve the targeted inclusion rate and scale the business as expected. The Company will attempt to compensate with spot market sales, but the outlook for this business has been tempered in the interim.
• Value-Add business on a recovery path from second quarter disruptions. The Company has resolved the production issues that impacted second quarter's results and is rebuilding sales momentum. Nevertheless, another year-over-year decline in sales and continued issues with imported feedstock contributed to a negative contribution from this business in the third quarter. The Company is exhibiting new products this week at Supply Side West, a major industry trade show, and expects these introductions to support a return to growth and a significant improvement in profitability in 2023.

Third Quarter 2022 Financial Highlights

"We continue to see strong demand for all our products, with total revenue growing 48% year-over-year in the third quarter," commented RiceBran's CFO and COO Todd Mitchell. "Despite strong top line growth, we continue to see higher than expected losses from a variety of factors which are being addressed. We are working hard to recover and develop new people for critical roles to drive operational improvements and believe that we are making substantial progress on this front. We are advancing the initiatives we highlighted last quarter to improve profitability, and we are optimistic that these efforts will bear fruit in the form of improved results in the fourth quarter, accelerating into 2023 and beyond."

• Revenue momentum remained strong in the third quarter. Total revenue was $10.3 million in 3Q22, up from $6.9 million in 3Q21. The 48% year-over-year increase in the quarter was underpinned by strong growth for Golden Ridge and MGI, as well as the third consecutive quarter of double-digit growth in Core-SRB sales. Sales growth in the third quarter was offset in part by a double-digit year-over-year decline in Value-Add SRB derivative sales, albeit improved sequentially from second quarter levels. The Company expects revenues in the fourth quarter to mirror levels in the first three quarters of 2022.
• Continued challenges resulted in higher gross losses. Gross losses were $697,000 in 3Q22, up from gross losses of $276,000 in 3Q21. The increase in gross losses reflected an increase in gross losses from Golden Ridge due to higher operating expenses to address deferred maintenance ahead of the mill's transition to a new sourcing and selling model, as well as a negative contribution margin from the Company's Value-Add SRB derivative business due to cost overruns associated with reaccelerating production and sourcing raw materials for new product introductions.
• Efficiencies keep SG&A stable in an inflationary environment. SG&A declined 2% year-over-year to $1.8 million. Upward pressure on costs has been offset by increased productivity and reductions in head count. Due to the increase in gross losses, operating losses grew 19% in 3Q22 to $2.5 million from operating losses of $2.1 million in 3Q21, while net losses were $2.0 million, or ($0.38) per share, versus net losses of $2.2 million, or ($0.47) per share a year ago. Net losses in the second quarter included a $0.6 million non-cash benefit from the revaluation of a warrant liability.
• Adjusted EBITDA (non-GAAP*) losses expanded. Adjusted EBITDA losses (non-GAAP) were $1.4 million in 3Q22, up from adjusted EBITDA losses (non-GAAP) of $1.1 million in 2Q21. This increase in the quarter reflected higher gross losses due to the year-over-year increase in gross losses from Golden Ridge, and the negative contribution margin in the quarter from the Value-Add SRB derivatives business. On a year-to-date basis, the contribution to adjusted EBITDA from Golden Ridge is now negative, while the similar contribution from Value-Add sales was down over $1.4 million from the same period in 2021.
• Steps taken to maintain sufficient liquidity. Total cash was $4.4 million at the end of the third quarter, down from $5.1 [SA1] million at the end of the second quarter. Cash reserves were $3.6 million, and total borrowing excluding factoring was $4.3 million. Cash reserves and total borrowing include the addition of $900,000 in liquidity that was provided in advance of a restructuring of Golden Ridge's term loan. After the end of the quarter, the Company raised net proceeds of $1.3 million from the issuance of common stock and warrants in a Registered Direct Offering managed by HC Wainwright.

Conference Call Information

RiceBran Technologies will host a conference call today, Thursday, November 3, at 4:30 p.m. Eastern Time to discuss these results. The call information is as follows:

• Date: November 3, 2022
• Time: 4:30 p.m. Eastern Standard Time
• Toll Free Dial-in number for US/Canada: 877-545-0320
• Dial-In number for international callers: 973-528-0002
• Participant Access Code: 594844
• Webcast: https://www.ricebrantech.com/investors

Following the conclusion of the live call, a replay of the webcast will be available on the Investor Relations section of the Company's website for at least 90 days. A telephonic replay of the conference call will also be available from 7 p.m. EST on November 3, 2022, until 11:59 p.m. EST on November 17, 2022 by dialing 877-481-4010 (United States) or 919-882-2331 (international) and using the passcode 47022.

About RiceBran Technologies

RiceBran Technologies is a specialty ingredient company focused on the development, production, and marketing of products derived from traditional and ancient small grains. Notably, we are a global leader in the production and marketing of stabilized rice bran (SRB), and high value-added derivative products derived from SRB, as well as a processor of rice, rice co-products, and barley and oat products. We create and produce products utilizing proprietary processes to deliver improved nutrition, ease of use, and extended shelf-life, while addressing consumer demand for all natural, non-GMO and organic products. The target markets for our products include food and animal nutrition manufacturers and retailers, as well as specialty food, functional food and nutritional supplement manufacturers and retailers, both domestically and internationally. More information can be found in the Company's filings with the SEC and by visiting our website at http://www.ricebrantech.com.

Forward-Looking Statements

This release contains forward-looking statements, including, but not limited to, statements about RiceBran's expectations regarding its future financial results, sales growth, adjusted EBITDA (non-GAAP) improvements, and SG&A. These statements are made based upon current expectations that are subject to known and unknown risks and uncertainties, including the risks that operations are disrupted by the COVID-19 pandemic and timing of profitable operations. RiceBran Technologies does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in RiceBran Technologies' filings with the Securities and Exchange Commission, including its most recent periodic reports.

Use of Non-GAAP Financial Information

We utilize "adjusted EBITDA" "Net Cash" and "Net Debt" as supplemental measures in our ongoing analysis of short term and long-term cash requirement and liquidity needs. Management uses adjusted EBITDA as an indicator of our current financial performance. By eliminating the impact of all material non-cash charges as well as items that do not regularly occur, we believe that adjusted EBITDA provides a more accurate and informative indicator of our cash requirements. Adjusted EBITDA does not represent cash flows from operations as defined by generally accepted accounting principles ("GAAP"), is not a measure derived in accordance with GAAP and should not be considered as an alternative to net income (the most comparable GAAP financial measure to adjusted EBITDA).

The tables below contain a reconciliation of net loss (GAAP) and adjusted EBITDA (non-GAAP) for the three and nine months ended September 30, 2022 and September 30, 2021, and for Net Cash (non-GAAP) and Net Debt (non-GAAP) for the periods ended September 30, 2022 and September 30, 2021. We do not provide a reconciliation of forward-looking net loss (GAAP) to adjusted EBITDA (non-GAAP). Due to the nature of certain reconciling items, it is not possible to predict with any reliability what future outcomes may be with regard to the expense or income that may ultimately be recognized in future periods. Any forward-looking adjusted EBITDA information that we may provide from time to time consistently excludes the same items from projected net loss that are excluded from actual net loss in the table below.

Investor Contact

Rob Fink
FNK IR
ribt@fnkir.com
646.809.4048

RiceBran Technologies
Consolidated Income Statement (Unaudited) (GAAP)
(in $000, except per share amounts)

RiceBran Technologies
Consolidated Balance Sheets (Unaudited)
(in $000)

RiceBran Technologies
Consolidated Statement of Cash Flows (Unaudited)
(in $000)

RiceBran Technologies
EBITDA and Adjusted EBITDA Reconciliation (Unaudited) (Non-GAAP)
(in $000)

RiceBran Technologies
Net Cash and Net Debt Reconciliation (Unaudited) (Non-GAAP)
(in $000)